Literature DB >> 28466760

Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients.

Salma I Patel1, Harini A Chakkera2, Paul W Wennberg3, David A Liedl3, Fadi Alrabadi4, Stephen S Cha5, Darren D Hooley6, Hatem Amer7, Hani M Wadei8, Fadi E Shamoun6.   

Abstract

Patients with end-stage renal disease undergoing kidney transplant often have diffuse atherosclerosis and high cardiovascular morbidity and mortality rates. We analyzed the correlation of peripheral arterial disease (PAD), here quantified by an abnormal ankle-brachial index (ABI) measured within the 5 years prior to kidney transplant, with graft failure and mortality rates (primary end points) after adjusting for known cardiovascular risk factors (age, sex, smoking history, hypertension, diabetes, stroke, known coronary artery disease or heart failure, years of dialysis). Of 1055 patients in our transplant population, 819 had arterial studies within the 5 years prior to transplant. Secondary end points included myocardial infarction; cerebrovascular accident; and limb ischemia, gangrene, or amputation. Low ABI was an independent and significant predictor of organ failure (OR, 2.77 (95% CI, 1.68-4.58), p<0.001), secondary end points (HR, 1.39 (95% CI, 0.97-1.99), p<0.076), and death (HR, 1.84 (95% CI, 1.26-2.68), p=0.002). PAD was common in this population: of 819 kidney transplant recipients, 46% had PAD. Low ABI was associated with a threefold greater risk of graft failure, a twofold greater risk of death after transplant, and a threefold greater risk of secondary end points. Screening for PAD is important in this patient population because of the potential impact on long-term outcomes.

Entities:  

Keywords:  ankle-brachial index (ABI); kidney; morbidity; mortality; peripheral arterial disease (PAD); transplantation

Mesh:

Year:  2017        PMID: 28466760     DOI: 10.1177/1358863X16689830

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  6 in total

Review 1.  Troubleshooting Complex Vascular Cases in the Kidney Transplant Recipient: Vascular Anomalies, Challenging Vessel Diseases, and Procedural Disasters.

Authors:  Vital Hevia; Victoria Gómez; Manuel Hevia; Javier Lorca; Marta Santiago; Ana Dominguez; Sara Álvarez; Víctor Díez; Cristina Gordaliza; Francisco Javier Burgos
Journal:  Curr Urol Rep       Date:  2020-02-04       Impact factor: 3.092

2.  Risk of post-transplant cardiovascular events in kidney transplant recipients with preexisting aortoiliac stenosis.

Authors:  Shabnam Babakry; Elsaline Rijkse; Joke I Roodnat; Diederik C Bijdevaate; Jan N M IJzermans; Robert C Minnee
Journal:  Clin Transplant       Date:  2021-11-09       Impact factor: 3.456

3.  Prevalence and Associations of Subclinical Peripheral Artery Disease among Patients with Type 2 Diabetes without Clinical Macrovascular Disease.

Authors:  Thilak P Weerarathna; Meththananda Herath; Gayani Liyanage; Miyuru K Weerarathna; Vidarsha Senadheera
Journal:  Int J Prev Med       Date:  2019-06-07

4.  Pre-operative ankle-brachial index for cardiovascular risk assessment in simultaneous pancreas-kidney transplant recipients: a simple and elegant strategy!

Authors:  Hans-Michael Hau; Nora Jahn; Max Brunotte; Tristan Wagner; Sebastian Rademacher; Daniela Branzan; Elisabeth Sucher; Daniel Seehofer; Robert Sucher
Journal:  BMC Surg       Date:  2021-03-22       Impact factor: 2.102

5.  Utility of a Simplified Iliac Artery Calcium Scoring System to Guide Perioperative Management for Renal Transplantation.

Authors:  Evan C Werlin; Hillary J Braun; Joy P Walker; Jonathan E Freise; Dominic Amara; Iris H Liu; Anna Mello; Mehdi Tavakol; Peter G Stock; Jade S Hiramoto
Journal:  Front Med (Lausanne)       Date:  2021-03-16

6.  Risk Factors of Cardiac Death for Elderly Patients with Severe Chronic Kidney Disease after Percutaneous Coronary Intervention.

Authors:  Ying Zhang; Guangyao Zhai; Jianlong Wang; Yujie Zhou
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.